Skip to content
TrackPodcasts
businessSep 24, 202540:59pending

Merck CEO & Kimmel’s Return 9/24/25

Squawk Pod

About this episode

The FDA has approved the injectable version of Merck’s cancer therapy Keytruda. Merck CEO Robert Davis discusses the pricing of this drug and others with CNBC’s Angelica Peebles, Joe Kernen, Becky Quick, and Andrew Ross Sorkin. Davis also stands firm on the safety of vaccines and weighs in on the Trump administration’s agenda for health care. Jimmy Kimmel has returned to ABC’s airwaves. Puck’s Matt Belloni discusses the host’s temporary suspension, Kimmel’s response, and the contractual obligations of Disney’s affiliates Nexstar and Sinclair. Plus, the U.S. has barred Iran’s diplomats from shopping at wholesale stores like Costco without permission. 

 

Matt Belloni - 15:12

Robert Davis - 28:47

 

In this episode

Matt Belloni, @mattbelloni

Joe Kernen, @JoeSquawk 

Becky Quick, @BeckyQuick

Andrew Ross Sorkin, @andrewrsorkin

Katie Kramer, @Kramer_Katie


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Get every episode summarized

Each time Squawk Pod publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Merck CEO & Kimmel’s Return 9/24/25

Squawk Pod

0:00
40:59

More episodes

More from Squawk Pod

View all episodes →